4571 NANO MRNA Co., Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4571

TSE Growth

NANO MRNA Co., Ltd.

142

JPY

-2

(-1.39%)

Dec 23, 3:30 pm JST

0.90

USD

Dec 23, 1:30 am EST

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	313	-1,302	-1,278	-2,835	-41.5	0	May 13, 2021	J-GAAP
Mar, 2022	264	-2,061	-1,925	-1,881	-26.9	0	May 12, 2022	J-GAAP
Mar, 2023	202	-1,246	-1,104	-1,310	-18.7	0	May 12, 2023	J-GAAP
Mar, 2024	135	-864	-749	-780	-11.1	0	May 14, 2024	J-GAAP
Mar, 2025 Guidance	108	-893	-856	-994	-14.1	0	Nov 14, 2024	J-GAAP
YoY	-20.0%	-3.4%	-14.3%	-27.4%	-26.8%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	May 14, 2019	581	-1,520	-1,536	-1,450	0	J-GAAP
	Apr 2, 2020	552	-1,143	-1,182	-2,047	0	J-GAAP
Results	May 13, 2020	552	-1,105	-1,144	-2,009	0	J-GAAP
Mar, 2021	May 13, 2020	Available in future release
	Nov 12, 2020
Results	May 13, 2021
Mar, 2022	May 13, 2021
Results	May 12, 2022
Mar, 2023	May 12, 2022
Results	May 12, 2023
Mar, 2024	May 12, 2023
	Feb 14, 2024
Results	May 14, 2024
Mar, 2025	May 14, 2024	51	-1,242	-1,192	-1,206	0	J-GAAP
	Nov 14, 2024	108	-893	-856	-994	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2003	96	－	Available in future release
Mar, 2004	122	+27.1
Mar, 2005	113	-7.4
Mar, 2006	107	-5.3
Mar, 2007	103	-3.7
Mar, 2008	262	+154.4
Mar, 2009	353	+34.7
Mar, 2010	117	-66.9
Mar, 2011	84	-28.2
Mar, 2012	346	+311.9
Mar, 2013	373	+7.8
Mar, 2014	472	+26.5
Mar, 2015	675	+43.0
Mar, 2016	243	-64.0
Mar, 2017	218	-10.3
Mar, 2018	259	+18.8
Mar, 2019	496	+91.5
Mar, 2020	552	+11.3
Mar, 2021	313	-43.3
Mar, 2022	264	-15.7
Mar, 2023	202	-23.5
Mar, 2024	135	-33.2
Mar, 2025 Guidance	108	-20.0	-893	-3.4	-856	-14.3	-14.1	-27.0

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	202	-1,246	-617	-26.77	-20.28	0.03	-18.7
Mar, 2024	135	-864	-640	-20.38	-14.37	0.02	-11.1
Mar, 2025 Guidance	108	-893	-827	-32.69	-20.97	0.02	-14.1

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	675	-144	-140	-141	-5.1
Fiscal Year	Mar, 2015	Mar, 2003	Mar, 2003	Mar, 2003	Mar, 2015

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	130	-1,029	-902	-906	-13.0	0	May 12, 2022	J-GAAP
Oct - Mar, 2022	111	-549	-504	-423	-6.0	0	May 12, 2023	J-GAAP
Oct - Mar, 2023	44	-346	-278	-303	-4.3	0	May 14, 2024	J-GAAP
Oct - Mar, 2024 Guidance	101	-520	-474	-476	-6.7	0	Nov 14, 2024	J-GAAP
YoY	+129.5%	-50.3%	-70.5%	-57.1%	-56.4%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	-2,061	-1,996	-1,752	-244	1,145	1,097	15.37	J-GAAP
Mar, 2023	-1,246	120	-1,087	1,207	ー	1,309	22.63	J-GAAP
Mar, 2024	-864	208	-585	793	3	1,575	31.06	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	91	-697	-600	-887	-12.7	ー	Nov 11, 2022	J-GAAP
Apr - Sep, 2023	91	-518	-471	-477	-6.8	ー	Nov 10, 2023	J-GAAP
Apr - Sep, 2024	7	-373	-382	-518	-7.4	ー	Nov 14, 2024	J-GAAP
YoY	-92.3%	+28.0%	+18.9%	-8.6%	-8.2%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	51	-395	-419	-112	-1.6	-774.5	Feb 14, 2023	J-GAAP
Jan - Mar, 2023	60	-154	-85	-311	-4.4	-256.7	May 12, 2023	J-GAAP
Apr - Jun, 2023	58	-304	-285	-285	-4.1	-524.1	Aug 10, 2023	J-GAAP
Jul - Sep, 2023	33	-214	-186	-192	-2.7	-648.5	Nov 10, 2023	J-GAAP
Oct - Dec, 2023	13	-169	-192	-260	-3.7	-1,300.0	Feb 14, 2024	J-GAAP
Jan - Mar, 2024	31	-177	-86	-43	-0.6	-571.0	May 14, 2024	J-GAAP
Apr - Jun, 2024	0	-189	-155	-156	-2.2	-Inf	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	7	-184	-227	-362	-5.1	-2,628.6	Nov 14, 2024	J-GAAP
YoY	-78.8%	+14.0%	-22.0%	-88.5%	-87.6%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	142	+20.3	Available in future release
Jan - Mar, 2020	117	-27.3
Apr - Jun, 2020	129	-11.6
Jul - Sep, 2020	64	-56.5
Oct - Dec, 2020	56	-60.6
Jan - Mar, 2021	64	-45.3
Apr - Jun, 2021	74	-42.6
Jul - Sep, 2021	60	-6.3
Oct - Dec, 2021	66	+17.9
Jan - Mar, 2022	64	0.0
Apr - Jun, 2022	20	-73.0
Jul - Sep, 2022	71	+18.3
Oct - Dec, 2022	51	-22.7
Jan - Mar, 2023	60	-6.3
Apr - Jun, 2023	58	+190.0
Jul - Sep, 2023	33	-53.5
Oct - Dec, 2023	13	-74.5
Jan - Mar, 2024	31	-48.3
Apr - Jun, 2024	0	-100.0
Jul - Sep, 2024	7	-78.8	-184	+14.0	-227	-22.0	-5.1	-88.9

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	317	45	312	310	7.7
Fiscal Year	Mar, 2015	Sep, 2011	Sep, 2014	Sep, 2014	Sep, 2014

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	79.08	77.6	7,136	5,536	-4,717	0.21	May 12, 2022	J-GAAP
Mar, 2023	60.61	73.5	5,784	4,251	-1,371	0.26	May 12, 2023	J-GAAP
Mar, 2024	48.39	67.1	5,071	3,405	-2,151	0.33	May 14, 2024	J-GAAP
Apr - Sep, 2024	ー	64.2	4,739	3,041	-2,669	0.36	Nov 14, 2024	J-GAAP

NANO MRNA Co., Ltd.(4571) Financial Results